June 15, 2025 (Boston) — We are glad to announce that Jenna Hebert, the Investment Director of RA Capital, will be presenting at the ACCESS CHINA BD Forum @BIO on June 15, 2025. ACCESS CHINA Biotech Forum is the largest corporate access event between Asia and the western biopharma industry.
About the speaker
Jenna Hebert is an Investment Director on the Venture Team at RA Capital Management, a multi-stage investment manager dedicated to company formation and evidence-based investing in healthcare and life science companies. Jenna focuses on identifying and diligencing opportunities for early-stage investments and advises RA’s portfolio companies. She currently serves as a board observer for Hemab, Alchemab Therapeutics, and Typewriter Therapeutics. Prior to RA, Jenna was an Analyst and Medical Writer at Costello Medical Consulting. Jenna has a B.A. in Neuroscience from University of Pennsylvania and a PhD in Neuroscience from the University of Oxford.
About ACCESS CHINA BD Forum @BIO
‘ACCESS CHINA BD Forum @BIO is scheduled to be held on June 15, 2025, at Seaport Boston Hotel. This year’s ACCESS CHINA BD Forum @BIO will convene 80 distinguished guests for an afternoon of strategic networking, business development, and thought leadership, with a special emphasis on China’s dynamic biotechnology landscape and global collaboration opportunities.
Conference Name: ACCESS CHINA BD Forum @BIO
Date: June 15, 2025
Content: Keynote Speeches, Panel Discussion, 10 Elevator Pitch, and Closed-Door Dinner Reception.
Participants: Pharma/Biotech senior management and BD’s
View more information at https://biotochina.org/
MORE INFORMATION
Contact us:
To register ACCESS CHINA online, please visit: ACCESS CHINA Biotech Forum
For more information, please contact:
Wendi Xiang
BioToChina.org 